News For Gilead Sciences


This RSS feed URL is deprecated

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google 11/21/2018 5:30:22 AM

Gilead HIV Prevention Pill Gets Backing From US Health Panel - Bloomberg


Bloomberg

Gilead HIV Prevention Pill Gets Backing From US Health Panel
Bloomberg
An influential U.S. health authority recommended an HIV prevention regimen using Gilead Sciences Inc.'s Truvada for people at high risk of getting the virus, saying they found it had a “substantial benefit” in preventing the disease. The draft ...
Everyone at high risk of HIV should be offered preventive meds, panel saysChicago Tribune
Panel recommends everyone at high risk of getting HIV be offered a prevention pillSTAT

all 20 news articles »
Google 11/20/2018 10:04:39 PM

The Drama Surrounding Dover Corporation (DOV), Gilead Sciences, Inc. (GILD) - The RNS Daily


Stock Digest

The Drama Surrounding Dover Corporation (DOV), Gilead Sciences, Inc. (GILD)
The RNS Daily
A look at DOV technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 55.58 point. Its trading volume has lost -516616 shares compared to readings over the past three months as it recently exchanged ...
3 Unknown but Amazing Dividend StocksMotley Fool
SEC FORM 4 - SEC.govSEC.gov

all 107 news articles »
Google 11/20/2018 7:24:00 PM

Analysts Perspectives: Gilead Sciences Inc (GILD) - ExpertGazette


ExpertGazette

Analysts Perspectives: Gilead Sciences Inc (GILD)
ExpertGazette
Gilead Sciences Inc (NASDAQ:GILD) shares traded -1.72% down during most recent session to reach at the closing price of $68.01. The stock exchanged hands 8.81 Million shares versus average trading capacity of 6.56 Million shares, yielding a market cap ...
Gilead Sciences, Inc. (GILD) Stock Ownership And Insider NewsPost Analyst
Key turning points to Take off: Gilead Sciences, Inc. (GILD), Huntsman Corporation (HUN)NMSU Nеws
RBC Capital Sees Imminent Gilead (GILD) CEO AnnouncementStreetInsider.com
Financial Mercury -Fairfield Current -News Room Alert (press release) -Seeking Alpha
all 120 news articles »
Google 11/20/2018 6:17:50 PM

Gilead Sciences to partner Tango Therapeutics on targeted oncology treatments pipeline - Zenopa


Gilead Sciences to partner Tango Therapeutics on targeted oncology treatments pipeline
Zenopa
Gilead Sciences, Inc. and Tango Therapeutics, Inc. are in partnership to discover, develop, and commercialize a pipeline of targeted immuno-oncology therapies. Tango will perform target discovery and validation, and Gilead will have options to ...

Google 11/20/2018 4:11:36 PM

Gilead Sciences, Inc. (GILD) registers a price change of -1.72% while Hutchison China MediTech Limited (HCM ... - Stocks Gallery


Stocks Gallery

Gilead Sciences, Inc. (GILD) registers a price change of -1.72% while Hutchison China MediTech Limited (HCM ...
Stocks Gallery
Gilead Sciences, Inc. (GILD) Stock Price Movement: In recent trading day Gilead Sciences, Inc. (GILD) stock showed the move of -1.72% with the closing price of $68.01. Closing price generally refers to the last price at which a stock trades during a ...

and more »
Google 11/20/2018 3:51:57 PM

TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead ... - PRNewswire (press release)


TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead ...
PRNewswire (press release)
20, 2018 /PRNewswire/ -- TARGET PharmaSolutions, Inc., a company focused on real world evidence, is pleased to announce that it has entered into a strategic partnership with Gilead Sciences for TARGET-NASH and TARGET-HBV. Gilead is the sixth ...
BRIEF—TARGET PharmaSolutions adds Gilead to its partnership listThe Pharma Letter

all 5 news articles »
Google 11/20/2018 1:47:32 PM

A better Deal: Sterling Bancorp (STL), Gilead Sciences, Inc. (GILD) - NMSU Nеws


NMSU Nеws

A better Deal: Sterling Bancorp (STL), Gilead Sciences, Inc. (GILD)
NMSU Nеws
The shares of Sterling Bancorp (NYSE:STL) went up during the trading session by $0.1 on Friday, trading at $18.64. At the moment, the company has a debt-to-equity ratio of 0.09. The stock has a 52-week low of $16.85 while its 52-weeks high is $26.50.

and more »
Google 11/19/2018 5:37:55 PM

 1 2